In most breast cancer susceptibility genes, Polish common founder mutations are present, including BRCA1, BRCA2, PALB2, and CHEK2, which constitute the majority (>80%) of all mutations detected in these genes in Polish women with breast cancer [43]. This evidence concerns the gene BRCA2 and breast carcinoma.